Skip to main content

Traws Pharma, Inc.

TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001130598

No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.

Superinvestors holding TRAW, Q2 2026

See all superinvestors

No superinvestor reported holding TRAW in Q2 2026.